skip to main content

Main Site Navigation

Top of main content

Clinical Trials Details

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

Location: Carle - Digestive Health Center
Body site or condition: Inflammatory Bowel Disease – Crohn’s Disease
Department: Digestive Health

CNTO1959CRD3001 - GALAXI

The purpose of this program is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Apply Now